S.I. No. 271/1999 -- Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 1999.
1999
271
|
|
|
|
|
STATUTORY INSTRUMENTS.
|
|
|
S.I. No. 271 of 1999.
|
|
|
|
|
|
MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS, 1999.
|
|
|
S.I. No. 271 of 1999.
|
|
|
MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS, 1999.
|
|
|
I, BRIAN COWEN, Minister for Health and Children, in exercise of the powers conferred on me by section 32 of the Irish Medicines Board Act, 1995 ( No. 29 of 1995 ), as adapted by the Health (Alteration of Name of Department and Title of Minister) Order, 1997 ( S.I. No. 308 of 1997 ), hereby make the following Regulations--
|
|
|
1. These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 1999.
|
|
|
2. These Regulations shall be construed as one with the Medicinal Products (Prescription and Control of Supply) Regulations, 1996 ( S.I. No. 256 of 1996 ) and the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 1996 ( S.I. No. 309 of 1996 ) and may be cited together with those Regulations as the Medicinal Products (Prescription and Control of Supply) Regulations, 1996 to 1999.
|
|
|
3. (1) Subject to paragraph (2) of this Regulation, these Regulations shall come into force on the 1st day of September, 1999.
|
|
|
(2) The provisions of Regulation 5(b) shall not come into operation until the 1st day of January, 2000.
|
|
|
4. In these Regulations--
|
|
|
“international non-proprietary name” or “INN” means the international non-proprietary name recommended by the World Health Organisation for pharmaceutical substances;
|
|
|
“the Principal Regulations” mean the Medicinal Products (Prescription and Control of Supply) Regulations, 1996.
|
|
|
5. The Principal Regulations are hereby amended by--
|
|
|
(a) the substitution in Regulation 4(1) of the following definition for “product authorisation”--
|
|
|
“‘product authorisation’ means an authorisation granted or in force in pursuance of the Medicinal Products (Licensing and Sale) Regulations, 1998 ( S.I. No. 142 of 1998 )”;
|
|
|
(b) the insertion in the First Schedule thereto of the various substances specified in Column 1 of the First Schedule to these Regulations and any entries that may appear in any of the Columns of the said First Schedule opposite the entry for each such substance;
|
|
|
(c) the substitution in the First Schedule thereto for the entries in respect of the various substances specified in Column 1 of the Second Schedule to these Regulations of the entries specified in the said Second Schedule and any entries that may appear in any of the Columns of the said Second Schedule opposite the entry for each such substance;
|
|
|
(d) the deletion in the Second Schedule thereto of the reference to “Regaine Topical Solution 2%;
|
|
|
(e) the insertion in Part 1 of the Third Schedule thereto of the substance “minoxidil”;
|
|
|
(f) the insertion in Part 1 of the Fourth Schedule thereto of the substance “diflorasone diacetate”; and
|
|
|
(g) the insertion in Part 2 of the Fourth Schedule thereto of the substance “cyproterone acetate”.
|
|
|
6. In the case of substances specified in Column 1 of the First Schedule of the Principal Regulations, where the name of the substance used is a name specified in Column 1 of the Third Schedule to these Regulations, such substance may also be known by the name (being the international non-proprietary name) as specified opposite the name of the said substance in Column 2 of the said Third Schedule.
|
|
|
FIRST SCHEDULE
|
|
|
Additional substances which when contained in medicinal products are subject to prescription control and circumstances excluding certain products from such control
|
|
|
|
Column 1
|
Column 2
|
Circumstances excluding medicinal products from prescription control
|
|
|
|
Column 3
|
Column 4
|
Column 5
|
|
Substance
|
Part in Schedule
|
Maximum strength, pack size or period of treatment
|
Use, pharmaceutical form or manner of administration
|
Maximum dose and maximum daily dose
|
|
19-nor-Androstenediol in its various isomeric forms
|
A
|
|
|
|
|
19-nor-Androstenedione in its various isomeric forms
|
A
|
|
|
|
|
19-nor-Testosterone
|
A
|
|
|
|
|
4-Hydroxybutanoic acid lactone (GBL)
|
A
|
|
|
|
|
4-Hydroxybutanoic acid, sodium salt (GBH)
|
A
|
|
|
|
|
Acamprosate
|
B
|
|
|
|
|
Alatrofloxacin
|
A
|
|
|
|
|
Amisulpride
|
B
|
|
|
|
|
Androstenediol in its various isomeric forms
|
A
|
|
|
|
|
Androstenediol in its various isomeric forms
|
A
|
|
|
|
|
Apraclonidine Hydrochloride
|
A
|
|
|
|
|
Arcitumomab
|
A
|
|
|
|
|
Aristolochia
|
A
|
|
|
|
|
Aristolochia Clematitis
|
A
|
|
|
|
|
Aristolochia Contorta
|
A
|
|
|
|
|
Aristolochia Debelis
|
A
|
|
|
|
|
Aristolochia Fang-chi
|
A
|
|
|
|
|
Aristolochia Manshuriensis
|
A
|
|
|
|
|
Aristolochia Serpentaria
|
A
|
|
|
|
|
Atorvastatin Calcium
|
B
|
|
|
|
|
Basiliximab
|
C
|
|
|
|
|
Becapiermin
|
A
|
|
|
|
|
Brimonidine Tartrate
|
B
|
|
|
|
|
Candesartan Cilexetil
|
B
|
|
|
|
|
Caulophyllum thalictroides Mich., the root thereof
|
A
|
|
|
|
|
Cefpirome Sulphate
|
A
|
|
|
|
|
Cefprozil
|
A
|
|
|
|
|
Cerivastatin Sodium
|
B
|
|
|
|
|
Cetrorelix Acetate
|
A
|
|
|
|
|
Chymopapain
|
A
|
|
|
|
|
Ciclopirox Olamine
|
B
|
|
|
|
|
Cidofovir
|
A
|
|
|
|
|
Clopidogrel Hydrogen Sulphate
|
B
|
|
|
|
|
Dactomycin
|
A
|
|
|
|
|
Deanol Aceglumate
|
B
|
|
|
|
|
Deanol Acetamidobenzoate
|
B
|
|
|
|
|
Desirudin
|
A
|
|
|
|
|
Deslorelin
|
A
|
|
|
|
|
Dexketoprofen
|
B
|
|
|
|
|
Dexketoprofen Trometamol
|
B
|
|
|
|
|
Didanosine
|
A
|
|
|
|
|
Diflorasone Diacetate
|
A
|
|
|
|
|
Diphtheria, Tetanus, Pertussis and Hepatitis B Vaccine
|
A
|
|
|
|
|
Dodecafluoropentane
|
C
|
|
|
|
|
Dolasetron Mesylate
|
A
|
|
|
|
|
Donepezil Hydrochloride
|
A
|
|
|
|
|
Doxorubicin Hydrochloride
|
A
|
|
|
|
|
Emedastine
|
B
|
|
|
|
|
Emedastine Difumarate
|
B
|
|
|
|
|
Entacapone
|
B
|
|
|
|
|
Eprosartan Mesylate Dihydrate
|
B
|
|
|
|
|
Estradiol Hemihydrate
|
A
|
|
|
|
|
Etonogestrel
|
A
|
|
|
|
|
Etoposide Phosphate
|
A
|
|
|
|
|
Fenoldopan Mesylate
|
A
|
|
|
|
|
Fenticonazole Nitrate
|
B
|
|
|
|
|
Ferristene
|
C
|
|
|
|
|
Fexofenadine Hydrochloride
|
B
|
|
|
|
|
Fluvastatin Sodium
|
B
|
|
|
|
|
Fosphenytoin
|
B
|
|
|
|
|
Fosphenytoin Sodium
|
B
|
|
|
|
|
Gadobenate Dimeglumine
|
C
|
|
|
|
|
Gadobenic Acid
|
C
|
|
|
|
|
Gemcitabine Hydrochloride
|
A
|
|
|
|
|
Grepafloxacin Hydrochloride Sesquihydrate
|
A
|
|
|
|
|
Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine
|
A
|
|
|
|
|
Hemin, Human
|
A
|
|
|
|
|
Hepatitis A Vaccine (Inactivated)
|
A
|
|
|
|
|
Hepatitis A Virus (Inactivated) and Hepatitis B Vaccine
|
A
|
|
|
|
|
Hypericum perforatum L (St. John's Wort)
|
B
|
|
External
|
|
|
Ibandronic Acid
|
B
|
|
|
|
|
Igovomab
|
A
|
|
|
|
|
Imiglucerase
|
A
|
|
|
|
|
Imiquimod
|
B
|
|
|
|
|
Indinavir
|
A
|
|
|
|
|
Interferon alfacon-1
|
A
|
|
|
|
|
Interferon Beta-1b
|
A
|
|
|
|
|
Interferon Beta-1a
|
A
|
|
|
|
|
Irbesartan
|
B
|
|
|
|
|
Irinotecan Hydrochloride Trihydrate
|
A
|
|
|
|
|
Lamivudine
|
A
|
|
|
|
|
Lanreotide Acetate
|
A
|
|
|
|
|
Latanoprost
|
A
|
|
|
|
|
Lepirudin
|
A
|
|
|
|
|
Letrozole
|
A
|
|
|
|
|
Levacetylmethadol
|
A
|
|
|
|
|
Levacetylmethadol Hydrochloride
|
A
|
|
|
|
|
Levocabastine Hydrochloride
|
B
|
|
|
|
|
Levofloxacin
|
A
|
|
|
|
|
Levoleucovorin Calcium
|
A
|
|
|
|
|
Lofepramine Hydrochloride
|
A
|
|
|
|
|
Magafodipir
|
C
|
|
|
|
|
Mannitol Hexanitrate
|
A
|
|
|
|
|
Mefenorex
|
A
|
|
|
|
|
Meloxicam
|
B
|
|
|
|
|
Mercaptamine Bitartrate
|
B
|
|
|
|
|
Metronidazole Benzoate
|
B
|
|
|
|
|
Mibefradil Dihydrochloride
|
B
|
|
|
|
|
Mibolerone
|
A
|
|
|
|
|
Miglitol
|
B
|
|
|
|
|
Mirtazapine
|
A
|
|
|
|
|
Mizolastine
|
B
|
|
|
|
|
Modafinil
|
A
|
|
|
|
|
Moexipril Hydrochloride
|
B
|
|
|
|
|
Montelukast Sodium
|
B
|
|
|
|
|
Nebivolol Hydrochloride
|
B
|
|
|
|
|
Nelfinavir Mesylate
|
A
|
|
|
|
|
Nevirapine
|
A
|
|
|
|
|
Nicofuranose
|
B
|
|
|
|
|
Nilvadipine
|
B
|
|
|
|
|
Nonacog alpha
|
A
|
|
|
|
|
Noxytiolin
|
A
|
|
|
|
|
Octafluoropropane
|
C
|
|
|
|
|
Olanzapine
|
A
|
|
|
|
|
Orlistat
|
A
|
|
|
|
|
Pancreatin
|
B
|
(1) 21,000 European Pharmacopoeia units of lipase per capsule (MS)
|
(1) Capsules
|
|
|
|
|
(2) 25,000 European Pharmacopoeia units of lipase per gram (MS)
|
(2) Powder
|
|
|
Penciclovir
|
A
|
|
|
|
|
Piperazine Adipate
|
B
|
|
|
|
|
Piperazine Citrate
|
B
|
|
|
|
|
Piperazine Hydrate
|
B
|
|
|
|
|
Piperazine Phosphate
|
B
|
|
|
|
|
Pramipexole
|
B
|
|
|
|
|
Pregnenolone
|
A
|
|
|
|
|
Pregnenolone Succinate
|
A
|
|
|
|
|
Proparacaine Hydrochloride
|
B
|
|
|
|
|
Rabeprazole
|
B
|
|
|
|
|
Raloxifene Hydrochloride
|
B
|
|
|
|
|
Reboxetine Methanesulphonate
|
A
|
|
|
|
|
Remifentanil Hydrochloride
|
A
|
|
|
|
|
Repaglinide
|
B
|
|
|
|
|
Reteplase
|
A
|
|
|
|
|
Ribavirin
|
A
|
|
|
|
|
Riluzole
|
A
|
|
|
|
|
Ritonavir
|
A
|
|
|
|
|
Rituximab
|
A
|
|
|
|
|
Rivastigmine
|
A
|
|
|
|
|
Ropinirole Hydrochloride
|
B
|
|
|
|
|
Rotavirus Vaccine
|
A
|
|
|
|
|
Samarium(153Sm) Lexidronam Pentasodium
|
C
|
|
|
|
|
Saquinavir Mesylate
|
A
|
|
|
|
|
Sertindole
|
A
|
|
|
|
|
Sidenafil Citrate
|
A
|
|
|
|
|
Sulesomab
|
C
|
|
|
|
|
Tacalcitol Monohydrate
|
B
|
|
|
|
|
Tacrolimus
|
A
|
|
|
|
|
Tamsulosin Hydrochloride
|
B
|
|
|
|
|
Tasonermin
|
A
|
|
|
|
|
Tazarotene
|
B
|
|
|
|
|
Telmisartan
|
B
|
|
|
|
|
Temozolomide
|
A
|
|
|
|
|
Tiagabine
|
B
|
|
|
|
|
Tiludronate Disodium
|
B
|
|
|
|
|
Tiludronic Acid
|
B
|
|
|
|
|
Tirofiban Hydrochloride
|
A
|
|
|
|
|
Tolcapone
|
B
|
|
|
|
|
Tolterodine L-Tartrate
|
B
|
|
|
|
|
Topiramate
|
B
|
|
|
|
|
Topotecan Hydrochloride
|
A
|
|
|
|
|
Torasemide Sodium
|
B
|
|
|
|
|
Tribulus terrestris L
|
B
|
|
|
|
|
Trifluridine
|
A
|
|
|
|
|
Trovafloxacin Mesylate
|
A
|
|
|
|
|
Urea-C13
|
A
|
|
|
|
|
Valsartan
|
B
|
|
|
|
|
Votumumab
|
C
|
|
|
|
|
Yellow Fever Vaccine (Live)
|
A
|
|
|
|
|
Yohimbine Bark
|
B
|
|
|
|
|
Zaleplon
|
A
|
|
|
|
|
Zanamivir
|
A
|
|
|
|
|
Zofenopril Calcium
|
B
|
|
|
|
|
Zolmitriptan
|
B
|
|
|
|
|
|
|
SECOND SCHEDULE
|
|
|
Substances which when contained in medicinal products are subject to prescription control and circumstances excluding certain products from such control
|
|
|
|
Column 1
|
Column 2
|
Circumstances excluding medicinal products from prescription control
|
|
|
|
Column 3
|
Column 4
|
Column 5
|
|
Substance
|
Part in Schedule
|
Maximum strength, pack size or period of treatment
|
Use, pharmaceutical form or manner of administration
|
Maximum dose and maximum daily does
|
|
Astemizole
|
B
|
|
|
|
|
Azelastine Hydrochloride
|
B
|
Container or package containing not more than 5,040 meg of Azelastine Hydrochloride
|
For nasal administration, in a non-aerosol, aqueous form
For the treatment of seasonal allergic rhinitis
For use in adults and children not less than 12 years
|
140 meg per nostril (MD)
280 meg per nostril (MDD)
|
|
Beclomethasone Dipropionate
|
B
|
Container or package containing not more than 9,000 mcg of Beclomethasone Dipropionate
3 months (MPT)
|
For the prevention and treatment of seasonal allergic rhinitis
In the form of a non-pressurised nasal spray
For use in persons aged 18 years and over
|
100 mcg per nostril (MD)
200 mcg per nostril (MDD)
|
|
Budesonide
|
B
|
|
|
|
|
Diclofenac Diethylammonium
|
B
|
Equivalent of 1.0% of Diclofenac (MS)
30.0 g (MPS)
7 days (MPT)
|
External
For local symptomatic relief of pain and inflammation in the trauma of the tendons, ligaments, muscles and joints and in localised forms of soft tissue rheumatism
For use in adults and children not less than 12 years
|
|
|
Famotidine
|
B
|
14 days (MPT)
|
Internal
For the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion, and hyperacidity, and the prevention of these symptoms when associated with food and drink, including nocturnal symptoms
|
10 mg (MD)
20 mg (MDD)
|
|
Felbinac
|
B
|
3.17% (MS)
|
External
|
|
|
|
|
30.0 g (MPS)
7 days (MPT)
|
For local symptomatic relief of pain and inflammation in the trauma of the tendons, ligaments, muscles and joints and in localised forms of soft tissue rheumatism
|
|
|
|
|
|
For use in adults and children not under 12 years
|
|
|
Flunisolide
|
B
|
0.025% (MS)
Container or package containing not more than 6,000 mcg of Flunisolide (MPS)
|
For the prevention and treatment of seasonal allergic rhinitis, including hay fever
In the form of a non-pressurised nasal spray
|
50 mcg per nostril (MD)
100 mcg per nostril (MDD)
|
|
|
|
3 months (MPT)
|
For use in persons aged 18 years and over
|
|
|
Fluticasone Propionate
|
B
|
|
|
|
|
Hydrocortisone acetate
|
A
|
(1) Equivalent to 1.0% of Hydro- cortisone (MS)
15.0 g (MPS)
|
(1) External
For use in irritant dermatitis, contact allergic dermatitis, insect bite reactions and mild to moderate eczema
|
|
|
|
|
|
For use in adults and children not under 10 years
|
|
|
|
|
(2) 10 mg (MS)
12 (MPS)
|
(2) External
In suppositories when in combination with one of more of the following: Benzyl Benzoate, Bismuth Oxide, Bismuth Subgalate, Peru Balsam, Pramoxine Hydrochloride, Zinc Oxide, for use in haemorrhoids.
|
|
|
|
|
|
For use in adults and children not under 10 years
|
|
|
Ibuprofen
|
B
|
(1) 50 (MPS)
200 mg (MS)
|
(1) Internal: Rheumatic and muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza
|
(1) 400 mg (MD)
1,200 mg (MDD)
|
|
|
|
(2) 5.0% 30 g (MPS)
|
(2) External: For local symptomatic relief of pain and inflammation in the trauma of the tendons, ligaments, muscles and joints and in localised forms of soft tissue rheumatism
|
|
|
Ketoprofen
|
B
|
2.5% (MS)
|
External
|
|
|
|
|
30.0 g (MPS)
7 days (MPT)
|
For local symptomatic relief of pain and inflammation in the trauma of the tendons, ligaments, muscles and joints and in localised forms of soft tissue rheumatism
|
|
|
|
|
|
For use in adults and children not under 12 years
|
|
|
Mefloquin Hydrochloride
|
B
|
|
|
|
|
Minoxidil
|
B
|
(1) 2%
|
(1) External: For application to the scalp
|
|
|
|
|
(2) 5%
|
(2) External: For application to the scalp in the treatment of alopecia androgenetica in persons aged 18 to 65 years
|
|
|
Naproxen Sodium
|
B
|
5% (MS)
|
External
|
|
|
|
|
30.0 g (MPS)
7 days (MPT)
|
For local symptomatic relief of pain and inflammation in the trauma of the tendons, ligaments, muscles and joints and in localised forms of soft tissue rheumatism
|
|
|
|
|
|
For use in adults and children not under 12 years
|
|
|
Nizatidine
|
B
|
8 (MPS)
14 days (MPT)
|
For the prevention of heartburn, indigestion and excess acid
|
75 mg (MD)
150 mg (MDD)
|
|
|
|
|
For use in adults and children not under 16 years
|
|
|
Piroxicam
|
B
|
0.5% (MS)
|
External
|
|
|
|
|
30.0 g (MPS)
7 days (MPT)
|
For local symptomatic relief of pain and inflammation in the trauma of the tendons, ligaments, muscles and joints and in localised forms of soft tissue rheumatism
|
|
|
|
|
|
For use in adults and children not under 12 years
|
|
|
Pseudoephedrine Hydrochloride
|
B
|
|
Internal:
|
|
|
|
|
(1) Ali prolonged release products
|
(1) 120 mg (MD) 240 mg (MDD)
|
|
|
|
|
(2) Any other product
|
(2) 60 mg (MD) 240 mg (MDD)
|
|
Pyridoxine Hydrochloride
|
B
|
|
|
50 mg (MDD)
|
|
Ranitidine Hydrochloride
|
B
|
14 days (MPT)
|
Internal
For the short term symptomatic relief of acid indigestion and heartburn
For use in adults and children not under 16 years
|
Equivalent to 75 mg of Ranitidine (MD)
Equivalent to 150 mg of Ranitidine (MDD)
|
|
Terfenadine
|
B
|
|
|
|
|
|
|
THIRD SCHEDULE
|
|
|
Substances specified in the First Schedule of the Principal Regulations for which there are International Non-proprietary Names recommended by the World Health Organisation
|
|
|
|
Name in First Schedule of Principal Regulations
|
International Non-proprietary Name (INN)
|
|
Column 1
|
Column 2
|
|
Acrosoxacin
|
Rosoxacin
|
|
Adrenaline
|
Epinephrine
|
|
Adrenaline Acid Tartrate
|
Epinephrine Acid Tartrate
|
|
Adrenaline Hydrochloride
|
Epinephrine Hydrochloride
|
|
Allyloestrenol
|
Allylestrenol
|
|
Alphadolone Acetate
|
Alfadolone Acetate
|
|
Alphaxalone
|
Alfaxalone
|
|
Amethocaine
|
Tetracaine
|
|
Amethocaine Gentisate
|
Tetracaine Gentisate
|
|
Amethocaine Hydrochloride
|
Tetracaine Hydrochloride
|
|
Amoxycillin
|
Amoxicillin
|
|
Amoxycillin Trihydrate
|
Amoxicillin Trihydrate
|
|
Amphetamine Sulphate
|
Amfetamine Sulphate
|
|
Amphomycin Calcium
|
Amfomycin Calcium
|
|
Amylobarbitone
|
Amobarbital
|
|
Amylobarbitone sodium
|
Amobarbital sodium
|
|
Barbitone
|
Barbital
|
|
Barbitone Sodium
|
Barbital Sodium
|
|
Beclomethasone
|
Beclometasone
|
|
Beclomethasone Dipropionate
|
Beclometasone Dipropionate
|
|
Bendrofluazide
|
Bendroflumethizide
|
|
Benoryiate
|
Benorilate
|
|
Benzathine penicillin
|
Benzathine benzylpenicillin
|
|
Benzhexol Hydochloride
|
Trihexyphenidyl Hydrochloride
|
|
Bethanidine Sulphate
|
Betanidine Sulphate
|
|
Busulphan
|
Busulfan
|
|
Butobarbitone
|
Butobarbital
|
|
Butobarbitone Sodium
|
Butobarbital Sodium
|
|
Cephalexin
|
Cefalexin
|
|
Cephalexin Sodium
|
Cefalexin Sodium
|
|
Cephaloridine
|
Cefaloridine
|
|
Cephalothin Sodium
|
Cefalotin Sodium
|
|
Cephamandole nafate
|
Cefamandole nafate
|
|
Cephazolin Sodium
|
Cefazolin Sodium
|
|
Cephradine
|
Cefradine
|
|
Chlorhexadol
|
Chloralodol
|
|
Chlormethiazole
|
Clomethiazole
|
|
Chlormethiazole Edisylate
|
Clomethiazole Edisilate
|
|
Chlorthalidone
|
Chlortalidone
|
|
Cholecalciferol
|
Colecalciferol
|
|
Clomiphene Citrate
|
Clomifene Citrate
|
|
Colistin Sulphomethate
|
Colistimethate
|
|
Colistin Sulphomethate Sodium
|
Colistimethate Sodium
|
|
Corticotrophin
|
Corticotropin
|
|
Cromoglycate, Sodium
|
Cromoglicate, Sodium
|
|
Cyclobarbitone
|
Cyclobarbital
|
|
Cyclobarbitone calcium
|
Cyclobarbital calcium
|
|
Cyclosporin
|
Ciclosporin
|
|
Danthron
|
Dantron
|
|
Deoxycortone Acetate
|
Desoxycortone Acetate
|
|
Deoxycortone Pivalate
|
Desoxycortone Pivalate
|
|
Dexamphetamine Sulphate
|
Dexamfetamine Sulphate
|
|
Diatrizoate Meglumine
|
Amidotrizoate Meglumine
|
|
Diatrizoate Sodium
|
Amidotrizoate Sodium
|
|
Diatrizoic acid
|
Amidotrizoic acid
|
|
Dichlorphenamide
|
Diclofenamide
|
|
Dicyclomine Hydrochloride
|
Dicycloverine Hydrochloride
|
|
Dienoestrol
|
Dienestrol
|
|
Dimethisoquin Hydrochloride
|
Quinisocaine Hydrochloride
|
|
Dothiepin
|
Dosulepin
|
|
Dothiepin Hydrochloride
|
Dosulepin Hydrochloride
|
|
Epithiazide
|
Epitizide
|
|
Ethacrynic acid
|
Etacrynic acid
|
|
Ethamivan
|
Etamivan
|
|
Ethinyloestradiol
|
Ethinylestradiol
|
|
Ethopropazine Hydrochloride
|
Profenamine Hydrochloride
|
|
Ethyloestrenol
|
Ethylestrenol
|
|
Ethynodiol Diacetate
|
Etynodiol Diacetate
|
|
Flurandrenolone
|
Fludroxycortide
|
|
Frusemide
|
Furosemide
|
|
Hexachlorophane
|
Hexachlorophene
|
|
Hexamine Hippurate
|
Methanamine Hippurate
|
|
Hexobarbitone
|
Hexobarbital
|
|
Hexobarbitone Sodium
|
Hexobarbital Sodium
|
|
Hydroxyprogesterone Hexanoate
|
Hydroxyprogesterone Caproate
|
|
Hydroxyurea
|
Hydroxycarbamide
|
|
Indomethacin
|
Indometacin
|
|
Iodipamide
|
Adipiodone
|
|
Iodipamide Meglumine
|
Adipiodone Meglumine
|
|
Iophendylate
|
Iofendylate
|
|
Iothalamic acid
|
Iotalamic acid
|
|
Lignocaine
|
Lidocaine
|
|
Lignocaine Hydrochloride
|
Lidocaine Hydrochloride
|
|
Lynoestrenol
|
Lynestrenol
|
|
Mefloquin Hydrochloride
|
Mefloquine Hydrochloride
|
|
Methallenoestrol
|
Methallenestrol
|
|
Methohexitone Sodium
|
Methohexital Sodium
|
|
Methoin
|
Mephenytoin
|
|
Methotrimeprazine
|
Levomepromazine
|
|
Methotrimeprazine Hydrochloride
|
Levomepromazine Hydrochloride
|
|
Methotrimeprazine Maleate
|
Levomepromazine Maleate
|
|
Methsuximide
|
Mesuximide
|
|
Methyleysteine Hydrochloride
|
Mecysteine Hydrochloride
|
|
Methylphenobarbitone
|
Methylphenobarbital
|
|
Mitozantrone Hydrochloride
|
Mitoxantrone Hydrochloride
|
|
Mustine Hydrochloride
|
Chlormethine Hydrochloride
|
|
Nicoumalone
|
Acenocoumarol
|
|
Noradrenaline
|
Norepinephrine
|
|
Noradrenaline Acid Tartrate
|
Norepinephrine Acid Tartrate
|
|
Octacosactrin
|
Tosactide
|
|
Oestradiol
|
Estradiol
|
|
Oestradiol Benzoate
|
Estradiol Benzoate
|
|
Oestradiol Cypionate
|
Estradiol Cipionate
|
|
Oestradiol Dipropionate
|
Estradiol Dipropionate
|
|
Oestradiol Diundecanoate
|
Estradiol Diundecanoate
|
|
Oestradiol Enanthate
|
Estradiol Enantate
|
|
Oestradiol Phenylpropionate
|
Estradiol Phenylpropionate
|
|
Oestradiol Undecanoate
|
Estradiol Undecanoate
|
|
Oestriol
|
Estriol
|
|
Oestriol Dihemisuccinate
|
Estriol Dihemisuccinate
|
|
Oestrone
|
Estrone
|
|
Oxethazaine
|
Oxetacaine
|
|
Oxpentifylline
|
Pentoxifylline
|
|
Pentobarbitone
|
Pentobarbital
|
|
Pentobarbitone Sodium
|
Pentobarbital Sodium
|
|
Phenbutrazate Hydrochloride
|
Fenbutrazate Hydrochloride
|
|
Phenethicillin Potassium
|
Pheneticillin Potassium
|
|
Phenobarbitone
|
Phenobarbital
|
|
Phenobarbitone Sodium
|
Phenobarbital Sodium
|
|
Phthalysulphathiazole
|
Phthalysulfathiazole
|
|
Procaine penicillin
|
Procaine benzylpenicillin
|
|
Quinalbarbitone
|
Secobarbital
|
|
Quinalbarbitone Sodium
|
Secobarbital Sodium
|
|
Salcatonin
|
Calcitonin (salmon)
|
|
Salcatonin Hydrated Polyacetate
|
Calcitonin (salmon) Hydrated Polyacetate
|
|
Secbutobarbitone
|
Secbutobarbital
|
|
Secbutobarbitone Sodium
|
Secbutobarbital Sodium
|
|
Sissomicin
|
Sisomicin
|
|
Sissomicin Sulphate
|
Sisomicin Sulphate
|
|
Stanolone
|
Androstanlone
|
|
Stilboestrol
|
Diethylstilbestrol
|
|
Stilboestrol Dipropionate
|
Diethylstilbestrol Propionate
|
|
Succinylsulphathiazole
|
Succinylsulfathiazole
|
|
Sulphacetamide
|
Sulfacetamide
|
|
Sulphacetamide Sodium
|
Sulfacetamide Sodium
|
|
Sulphadiazine
|
Sulfadiazine
|
|
Sulphadiazine Silver
|
Sulfadiazine Silver
|
|
Sulphadiazine Sodium
|
Sulfadiazine Sodium
|
|
Sulphadimidine
|
Sulfadimidine
|
|
Sulphadimidine Sodium
|
Sulfadimidine Sodium
|
|
Sulphafurazole
|
Sulfafurazole
|
|
Sulphafurazole Diethanolamine
|
Sulfafurazole Diethanolamine
|
|
Sulphaguanidine
|
Sulfaguanidine
|
|
Sulphaloxic acid
|
Sulfaloxic acid
|
|
Sulphamethizole
|
Sulfamethizole
|
|
Sulphamethoxazole
|
Sulfamethoxazole
|
|
Sulphamethoxydiazine
|
Sulfametoxydiazine
|
|
Sulphamethoxypyridazine
|
Sulfametoxypyridazine
|
|
Sulphamethoxypyridazine Sodium
|
Sulfametoxypyridazine Sodium
|
|
Sulphamoxole
|
Sulfamoxole
|
|
Sulphaphenazole
|
Sulfaphenazole
|
|
Sulphasalazine
|
Sulfasalazine
|
|
Sulphathiazole
|
Sulfathiazole
|
|
Sulphathiazole Sodium
|
Sulfathiazole Sodium
|
|
Sulphaurea
|
Sulfacarbamide
|
|
Sulphinpyrazone
|
Sulfinpyrazone
|
|
Tetracosactrin
|
Tetracosactide
|
|
Tetracosactrin Acetate
|
Tetracosactide Acetate
|
|
Thioguanine
|
Tioguanine
|
|
Thiopentone Sodium
|
Thiopental Sodium
|
|
Thymoxamine Hydrochloride
|
Moxisylyte Hydrochloride
|
|
Thyroxine Sodium
|
Levothyroxine Sodium
|
|
Trimeprazine
|
Alimemazine
|
|
Trimeprazine Tartrate
|
Alimemazine Tartrate
|
|
Troxidone
|
Trimethadione
|
|
Urofollitrophin
|
Urofollitropin
|
|
Vitamin A
|
Retinol
|
|
Vitamin A Acetate
|
Retinol Acetate
|
|
Vitamin A Palmitate
|
Retinol Palmitate
|
|
|
|
|
|
GIVEN under my Official Seal, this 27th day of August, 1999.
|
|
|
BRIAN COWEN,
|
|
|
Minister for Health and Children.
|
|
|
|
EXPLANATORY NOTE.
|
|
|
(This note is not part of the Instrument and does not purport to be a legal interpretation.)
|
|
|
The purpose of these regulations is to update the list of medicinal products which are subject to prescription-only controls, to de-regulate certain medicinal products currently only available on prescription, to adjust existing controls applicable to certain medicinal products and to identify certain substances by their International Non-Proprietary Names as recommended by the World Health Organisation.
|
